| |
Latest 10 SEC filings (by transaction date) for ME within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 6/22 | Dec 5/22 | Hibbs Kathy L | Direct Ownership | Class A Common Stock | S - Open market or private sale ![]() | -26,259 | $3.25 |
Nov 22/22 | Nov 20/22 | Selsavage Joseph Anthony | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -10,105 | $2.99 |
Nov 22/22 | Nov 20/22 | Hibbs Kathy L | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -4,628 | $2.99 |
Nov 22/22 | Nov 20/22 | Hillan Kenneth J. | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -4,628 | $2.99 |
Nov 14/22 | Nov 11/22 | Scheller Richard H | Direct Ownership | Class A Common Stock | S - Open market or private sale ![]() | -18,421 | $3.24 |
Nov 4/22 | Nov 4/22 | Gsk Plc | Indirect Ownership | Class B Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities ![]() | ||
Sep 8/22 | Sep 6/22 | Mohan Neal | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 14,633 | |
Sep 8/22 | Sep 6/22 | Scheller Richard H | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 14,633 | |
Sep 8/22 | Sep 6/22 | Botha Roelof | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 3,251 | $3.08 |
Sep 8/22 | Sep 6/22 | Botha Roelof | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 14,633 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ME within the last 6 months | [?] |
![]() ![]() |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Dec 6/22 | Dec 5/22 | Hibbs Kathy L | Direct Ownership | Class A Common Stock | S - Open market or private sale ![]() | -26,259 | $3.25 |
Nov 22/22 | Nov 20/22 | Selsavage Joseph Anthony | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -10,105 | $2.99 |
Nov 22/22 | Nov 20/22 | Hibbs Kathy L | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -4,628 | $2.99 |
Nov 22/22 | Nov 20/22 | Hillan Kenneth J. | Direct Ownership | Class A Common Stock | F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 ![]() | -4,628 | $2.99 |
Nov 14/22 | Nov 11/22 | Scheller Richard H | Direct Ownership | Class A Common Stock | S - Open market or private sale ![]() | -18,421 | $3.24 |
Nov 4/22 | Nov 4/22 | Gsk Plc | Indirect Ownership | Class B Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities ![]() | ||
Sep 8/22 | Sep 6/22 | Mohan Neal | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 14,633 | |
Sep 8/22 | Sep 6/22 | Scheller Richard H | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 14,633 | |
Sep 8/22 | Sep 6/22 | Botha Roelof | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 3,251 | $3.08 |
Sep 8/22 | Sep 6/22 | Botha Roelof | Direct Ownership | Class A Common Stock | A - Grant, award or other under Rule 16b-3(d) ![]() | 14,633 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
No competitors with recent insider filings. |